Drug Allergy in Children: Adverse Reactions after Skin Testing

被引:0
|
作者
Karavaizoglu, Cagla [1 ]
Suleyman, Ayse [1 ]
Yavuz Alic, Roza [2 ]
Dolu, Kazim Okan [1 ]
Yucel, Esra [1 ]
Demirkale, Zeynep Hizli [1 ]
Cimen, Sevgi Sipahi [1 ]
Ozdemir, Cevdet [1 ,3 ]
Tamay, Zeynep Ulker [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Pediat, Div Pediat Allergy & Immunol, Istanbul, Turkiye
[2] Istanbul Univ, Istanbul Fac Med, Dept Pediat, Istanbul, Turkiye
[3] Istanbul Univ, Inst Child Hlth, Dept Pediat Basic Sci, Istanbul, Turkiye
关键词
Adverse reaction; Anaphylaxis; Children; Drug skin tests; Safety; SYSTEMIC REACTIONS; HYPERSENSITIVITY; PRICK; IMMUNOTHERAPY; FATALITIES;
D O I
10.1159/000533641
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Skin tests are one of the most widely used diagnostic tools for suspected drug allergies in children. Studies on systemic reactions occurring during skin testing with allergens have mostly been conducted in pediatric and adult patient groups together. However, data on adverse reactions including allergic reactions after drug skin tests in children are scarce. It is aimed to determine the adverse reactions after skin test in children with suspected drug allergy. Methods: Patients who underwent a drug skin test due to the suspicion of drug allergy between May 2017 and June 2020 were evaluated, retrospectively. Data about adverse reactions seen after skin testing at the testing area in the clinic were analyzed. Results: The study included 1,073 children (585 [54.5%] boys and 488 [45.5%] girls) with a median age of 7.5 years. A total of 12 (1.1%) reactions were detected after skin testing, and 4 (0.4%) of them were allergic reactions. Of the allergic reactions, three were anaphylaxis and one was urticaria. Two of the reactions (1 anaphylaxis and 1 urticaria) were detected after the skin prick test and the remaining 2 were detected after intradermal test. Three of the nonallergic reactions were considered as vasovagal reactions and seven were considered as nonspecific and anxiety-related reactions. Conclusion: Although drug skin tests were generally well-tolerated and adverse reactions were rare, severe allergic reactions including anaphylaxis may ensue. Skin tests should be necessarily performed in clinical settings in experienced centers.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条
  • [42] Children and ADRs (Adverse Drug Reactions)
    Ettore Napoleone
    Italian Journal of Pediatrics, 36
  • [43] Pitfalls in drug allergy skin testing: false-positive reactions due to (hidden) additives
    Grims, RH
    Kranke, B
    Aberer, W
    CONTACT DERMATITIS, 2006, 54 (05) : 290 - 294
  • [44] Pilot testing of checklists to discern adverse drug reactions and adverse drug events
    Chen, Aleda M. H.
    Kiersma, Mary E.
    Shepler, Brian M.
    Murawski, Matthew M.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2013, 53 (01) : 61 - 69
  • [45] Anaphylaxis After Oxaliplatin Allergy Skin Testing
    Martin-Lazaro, J.
    Firvida, J. L.
    Berges-Gimeno, P.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2014, 24 (04) : 269 - 270
  • [46] Allergy testing in patients suspected to local anesthetics adverse reactions
    Marsenic, M.
    Simjanovska, L.
    Stoleski, S.
    Mijakoski, D.
    ALLERGY, 2010, 65 : 250 - 250
  • [47] In vivo and in vitro testing for adverse drug reactions
    Rieder, MJ
    PEDIATRIC CLINICS OF NORTH AMERICA, 1997, 44 (01) : 93 - &
  • [48] Systemic reactions to skin tests in suspected drug allergy
    Damasceno, P.
    Domingues, M.
    Nascimento, L.
    Arteaga, V
    Chieza, C.
    Capelo, A., V
    Silva, E.
    Rubini, N.
    ALLERGY, 2021, 76 : 263 - 264
  • [49] Patch testing for cutaneous adverse drug reactions
    Pitney, L.
    Spelman, L.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 22 - 22
  • [50] Patch testing in cutaneous adverse drug reactions: Experience from a UK tertiary referral allergy centre
    Jayasundera, Joseph
    Leck, Claire
    Dashi-Smaili, Xhoana
    Barachina, Elizabeth
    Angel, Dayana
    Billahalli, Thippeswamy
    Watts, Timothy
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 793 - 793